Anticoagulants Market Analysis, by Application (Stroke, Atrial Fibrillation & Heart Attack), by Route of Administration (Injectable anticoagulant), by Drug Class (Vitamin K Antagonist), by Distribution Channel (Online Pharmacy), and by Region - Global Forecast to 2022-2033

The anticoagulants market size is estimated to be USD 35,475.2 million in 2022 and is expected to witness a CAGR of 10.35% during the forecast period 2023-2033. The increasing use of new oral anticoagulants (NOACs), growing incidence of cardiovascular diseases and venous thromboembolism (VTE), rising unmet requirements, escalating number of obese and old persons, and a surge in demand for innovative therapies are factors contributing to the market growth. However, the increased cost of NOACs, increased risk of adverse effects, absence of NOAC countermeasures, and strict regulatory environment are expected to hinder growth.

Segmentation

By Application

On the basis of application, the market is segmented into stroke, atrial fibrillation & heart attack, pulmonary embolism (PE), deep vein thrombosis (DVT), and others. In 2022, the atrial fibrillation & heart attack segment held the highest market share owing to the growing usage of anticoagulants in the treatment of various disorders and a sizable target population.

By Route of Administration

Based on route of administration, the market is bifurcated into injectable anticoagulants and oral anticoagulants. In 2022, the oral anticoagulants segment held the highest market share owing to technical improvements in anticoagulants, and their significant risk-reduction impact.

By Drug Class

On the basis of drug class, the market is segregated into vitamin k antagonists, heparin & LMWH, NOACs, and others. In 2022, the NOACs segment held the highest market share owing to the increasing use of NOACs in comparison to warfarin, and NOACs provide a number of benefits over warfarin.

By Distribution Channel

Based on distribution channel, the market is divided into online pharmacy, hospital pharmacy, retail pharmacy. In 2022, the hospital pharmacy segment held the highest market share owing to the fact that it offers a number of advantages, including better access to medications.

Regional Markets

In 2022, North America region accounted for the highest revenue in the anticoagulants market and is expected to maintain its dominance during the forecast period. This is attributed to the expanding R&D initiatives, rising knowledge and widespread occurrence of risk factors like diabetes and obesity in the populace, regional introductions of new products, and the increased incidence of cardiovascular conditions that need anticoagulants for treatment. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing frequency of cardiovascular diseases, growing knowledge of cardiovascular diseases, surging regional disposable incomes, and acceptance of advanced blood thinners.

Competitor Insights

Some of the key players operating in the anticoagulants market are Sanofi S.A. (France), Portola Pharmaceuticals, Inc. (US), Pfizer, Inc. (US), Johnson & Johnson (US), GlaxoSmithKline plc. (UK), Daiichi Sankyo Company Limited (Japan), Bristol-Myers Squibb Company (US), Boehringer Ingelheim GmbH (Germany), Bayer AG (Germany), and Aspen Holdings (South Africa).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including application, route of administration, drug class, and distribution channel from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 35,475.2 Million
CAGR
  • 10.35%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Application
  • Route of Administration
  • Drug Class
  • Distribution Channel
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Anticoagulants Market Report 2022 – 2033

Application (Revenue, USD Million), 2022 – 2033

  • Stroke
  • Atrial fibrillation & heart attack
  • Pulmonary embolism (PE)
  • Deep vein thrombosis (DVT)
  • Others

Route of Administration (Revenue, USD Million), 2022 – 2033

  • Injectable anticoagulant
  • Oral anticoagulant

Drug Class (Revenue, USD Million), 2022 – 2033

  • Vitamin K Antagonist
  • Heparin & LMWH
  • NOACs
    • Pradaxa
    • Savaysa & lixiana
    • Eliquis
    • Xarelto
    • Bevyxxa
  • Others

Distribution Channel (Revenue, USD Million), 2022 – 2033

  • Online Pharmacy
  • Hospital Pharmacy
  • Retail Pharmacy

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Anticoagulants Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Anticoagulants
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Anticoagulants Market 
  3. Market Analysis by Application
    1. Stroke
      1. Stroke Market Forecast, 2022-2033 (USD Million)
    2. Atrial fibrillation & heart attack
      1. Atrial fibrillation & heart attack Market Forecast, 2022-2033 (USD Million)
    3. Pulmonary embolism (PE)
      1. Pulmonary embolism (PE) Market Forecast, 2022-2033 (USD Million)
    4. Deep vein thrombosis (DVT)
      1. Deep vein thrombosis (DVT) Market Forecast, 2022-2033 (USD Million)
    5. Others
      1. Others Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Route of Administration
    1. Injectable anticoagulant
      1. Injectable anticoagulant Market Forecast, 2022-2033 (USD Million)
    2. Oral anticoagulant
      1. Oral anticoagulant Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Drug Class
    1. Vitamin K Antagonist
      1. Vitamin K Antagonist Market Forecast, 2022-2033 (USD Million)
    2. Heparin & LMWH
      1. Heparin & LMWH Market Forecast, 2022-2033 (USD Million)
    3. NOACs
      1. NOACs Market Forecast, 2022-2033 (USD Million)
        1. Pradaxa
          1. Pradaxa Market Forecast, 2022-2033 (USD Million)
        2. Savaysa & lixiana
          1. Savaysa & lixiana Market Forecast, 2022-2033 (USD Million)
        3. Eliquis
          1. Eliquis Market Forecast, 2022-2033 (USD Million)
        4. Xarelto
          1. Xarelto Market Forecast, 2022-2033 (USD Million)
        5. Bevyxxa
          1. Bevyxxa Market Forecast, 2022-2033 (USD Million)
        6. Others
          1. Others Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Distribution Channel
    1. Online Pharmacy
      1. Online PharmacyMarket Forecast, 2022-2033 (USD Million)
    2. Hospital Pharmacy
      1. Hospital PharmacyMarket Forecast, 2022-2033 (USD Million)
    3. Retail Pharmacy
      1. Retail PharmacyMarket Forecast, 2022-2033 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North AmericaAnticoagulants Market  
    1. North AmericaAnticoagulants Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Application, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
        3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. S.Anticoagulants Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Application, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
          3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. CanadaAnticoagulants Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Application, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
            3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. EuropeAnticoagulants Market  
    1. EuropeAnticoagulants Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Application, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
        3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. GermanyAnticoagulants Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Application, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
          3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. UKAnticoagulants Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Application, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
            3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. FranceAnticoagulants Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Application, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
              3. Market Size and Forecast byDrug Class, 2022-2033 (USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
            2. SpainAnticoagulants Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Application, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
                3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
              2. ItalyAnticoagulants Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Application, 2022-2033(USD Million)
                  2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                  4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
                2. Rest of EuropeAnticoagulants Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Application, 2022-2033(USD Million)
                    2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                    4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. Asia PacificAnticoagulants Market  
    1. Asia PacificAnticoagulants Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Application, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
        3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. JapanAnticoagulants Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Application, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
          3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. ChinaAnticoagulants Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Application, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
            3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. IndiaAnticoagulants Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Application, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
              3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
            2. South KoreaAnticoagulants Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Application, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
                3. Market Size and Forecast by Drug Class,2022-2033 (USD Million)
                4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
              2. AustraliaAnticoagulants Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Application, 2022-2033(USD Million)
                  2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Drug Class 2022-2033(USD Million)
                  4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
                2. Rest of Asia PacificAnticoagulants Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Application, 2022-2033(USD Million)
                    2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                    4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. Latin America Anticoagulants Market  
    1. Latin AmericaAnticoagulants Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Application, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
        3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. BrazilAnticoagulants Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
          3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. MexicoAnticoagulants Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Application, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
            3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. ArgentinaAnticoagulants Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Application, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
              3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
            2. Rest of Latin AmericaAnticoagulants Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Application, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
                3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. MEAAnticoagulants Market  
    1. MEAAnticoagulants Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Application, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
        3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. GCCAnticoagulants Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Application, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
          3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. South AfricaAnticoagulants Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Application, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
            3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. Rest of MEAAnticoagulants Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Application, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033 (USD Million)
              3. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Sanofi S.A. (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Portola Pharmaceuticals, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Pfizer, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Johnson & Johnson (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. GlaxoSmithKline plc. (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Daiichi Sankyo Company Limited (Japan)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Bristol-Myers Squibb Company (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Boehringer Ingelheim GmbH (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Bayer AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Aspen Holdings (South Africa)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
  1. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.